Sinphar Pharmaceutical Co., Ltd. (1734)
Market Closed
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
31. 60
-0.1
-0.3155%
NT$
5.92B Market Cap
13.52 P/E Ratio
3.81% Div Yield
216,156 Volume
4.68 Eps
NT$ 31.7
Previous Close Want to track 1734 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinphar Pharmaceutical Co., Ltd. (1734) Statistics
Valuation metrics
Market Cap 5.92B
Enterprise value 7.1B
Trailing P/E (ttm) 17.42
Forward P/E -
PEG ratio 1.99
Price/Sales (ttm) 1.89
Price/Book (mrq) 1.76
Enterprise Value/Revenue 2.06
Enterprise Value/EBITDA 10.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 155.66K
Average volume (90 days) 263.43K
Price summary
52-Week low 26.52
52-Week high 32.8
Beta -
50-Day moving average 31.46
200-Day moving average 31.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.94
Trailing annual dividend yield 0.0291%
5-Year annual dividend yield -
Payout ratio 0.52
Dividend Date 28 Aug 2026
Ex-Dividend Date 24 Jul 2026
Last split factor 1,060:1,000
Last split Date 27 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 18.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0.59
Current ratio (mrq) 2.04%
Book value per share (mrq) 19.82
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
